385 related articles for article (PubMed ID: 3522770)
1. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
2. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Fieldsteel AH; Levy L
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
[TBL] [Abstract][Full Text] [Related]
3. Dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Fieldsteel AH; Levy L
Am J Trop Med Hyg; 1976 Nov; 25(6):854-9. PubMed ID: 795312
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of four rodent systems to monitor initial therapy of lepromatous leprosy: in search of a more sensitive system to assess bacterial viability.
Gelber RH; Humphres RC; Fieldstell AH
Acta Leprol; 1984; 2(2-4):319-25. PubMed ID: 6398591
[No Abstract] [Full Text] [Related]
6. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
7. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
8. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
[TBL] [Abstract][Full Text] [Related]
9. Detection of persisting Mycobacterium leprae by inoculation of the neonatally thymectomized rat.
Gelber RH; Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):872-8. PubMed ID: 3325581
[No Abstract] [Full Text] [Related]
10. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
[TBL] [Abstract][Full Text] [Related]
11. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
[TBL] [Abstract][Full Text] [Related]
12. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
[No Abstract] [Full Text] [Related]
13. Persister M. leprae after introductory rifampicin followed by dapsone therapy.
Sreevatsa ; Girdhar BK; Desikan KV
Lepr India; 1981 Jul; 53(3):350-3. PubMed ID: 7278139
[TBL] [Abstract][Full Text] [Related]
14. Intermittent rifampicin therapy in lepromatous leprosy.
Girdhar BK; Sreevatsa ; Desikan KV
Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
16. Effect of simultaneous administration of interferon-gamma and chemotherapy against Mycobacterium leprae in experimental infection in nude mice.
Banerjee DK; McDermott-Lancaster RD
Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):690-6. PubMed ID: 2126271
[TBL] [Abstract][Full Text] [Related]
17. Relationship between T-cell population in neonatally thymectomized Lewis rats and susceptibility to infection with mycobacterium leprae.
Fieldsteel AH; Sato N; Colston MJ
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):317-23. PubMed ID: 7033149
[TBL] [Abstract][Full Text] [Related]
18. Rifampin therapy of lepromatous leprosy.
Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
20. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
